122 related articles for article (PubMed ID: 18316769)
1. Update in pulmonary arterial hypertension 2007.
Humbert M
Am J Respir Crit Care Med; 2008 Mar; 177(6):574-9. PubMed ID: 18316769
[No Abstract] [Full Text] [Related]
2. [Pulmonary arterial hypertension--a rare form of pulmonary hypertension].
Schenk M
Dtsch Med Wochenschr; 2010 May; 135(21):p21. PubMed ID: 20509110
[No Abstract] [Full Text] [Related]
3. BMPR2 mutation and outcome in pulmonary arterial hypertension: clinical relevance to physicians and patients.
Rubin LJ
Am J Respir Crit Care Med; 2008 Jun; 177(12):1300-1. PubMed ID: 18522952
[No Abstract] [Full Text] [Related]
4. Improved Survival of Patients with Pulmonary Arterial Hypertension with BMPR2 Mutations in the Last Decade.
Isobe S; Kataoka M; Aimi Y; Gamou S; Satoh T; Fukuda K
Am J Respir Crit Care Med; 2016 Jun; 193(11):1310-4. PubMed ID: 27248591
[No Abstract] [Full Text] [Related]
5. Pulmonary arterial hypertension preceding idiopathic pulmonary fibrosis in a BMPR2 mutation positive patient.
Raamsteeboers AJ; Bogaard HJ; Vonk Noordegraaf A
Eur Respir Rev; 2014 Mar; 23(131):147-9. PubMed ID: 24591673
[No Abstract] [Full Text] [Related]
6. Genetics of pulmonary arterial hypertension: current and future implications.
Elliott CG
Semin Respir Crit Care Med; 2005 Aug; 26(4):365-71. PubMed ID: 16121312
[TBL] [Abstract][Full Text] [Related]
7. Genes and pulmonary arterial hypertension.
Sztrymf B; Yaïci A; Girerd B; Humbert M
Respiration; 2007; 74(2):123-32. PubMed ID: 17318011
[TBL] [Abstract][Full Text] [Related]
8. Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation.
Frydman N; Steffann J; Girerd B; Frydman R; Munnich A; Simonneau G; Humbert M
Eur Respir J; 2012 Jun; 39(6):1534-5. PubMed ID: 22654007
[No Abstract] [Full Text] [Related]
9. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
Li W; Hu H
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.
Girerd B; Montani D; Coulet F; Sztrymf B; Yaici A; Jaïs X; Tregouet D; Reis A; Drouin-Garraud V; Fraisse A; Sitbon O; O'Callaghan DS; Simonneau G; Soubrier F; Humbert M
Am J Respir Crit Care Med; 2010 Apr; 181(8):851-61. PubMed ID: 20056902
[TBL] [Abstract][Full Text] [Related]
11. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of genetic mutation and modifier genes in pulmonary arterial hypertension].
Fujiwara M; Yagi H; Matsuoka R; Saji T
Nihon Rinsho; 2008 Nov; 66(11):2071-5. PubMed ID: 19051722
[TBL] [Abstract][Full Text] [Related]
13. Early onset severe pulmonary arterial hypertension with 'two-hit' digenic mutations in both BMPR2 and KCNA5 genes.
Wang G; Knight L; Ji R; Lawrence P; Kanaan U; Li L; Das A; Cui B; Zou W; Penny DJ; Fan Y
Int J Cardiol; 2014 Dec; 177(3):e167-9. PubMed ID: 25189502
[No Abstract] [Full Text] [Related]
14. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.
Chida A; Shintani M; Yagi H; Fujiwara M; Kojima Y; Sato H; Imamura S; Yokozawa M; Onodera N; Horigome H; Kobayashi T; Hatai Y; Nakayama T; Fukushima H; Nishiyama M; Doi S; Ono Y; Yasukouchi S; Ichida F; Fujimoto K; Ohtsuki S; Teshima H; Kawano T; Nomura Y; Gu H; Ishiwata T; Furutani Y; Inai K; Saji T; Matsuoka R; Nonoyama S; Nakanishi T
Am J Cardiol; 2012 Aug; 110(4):586-93. PubMed ID: 22632830
[TBL] [Abstract][Full Text] [Related]
15. Treatment of primary pulmonary hypertension -- the next generation.
Newman JH
N Engl J Med; 2002 Mar; 346(12):933-5. PubMed ID: 11907295
[No Abstract] [Full Text] [Related]
16. [Female gender and pulmonary arterial hypertension: a complex relationship].
Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
[TBL] [Abstract][Full Text] [Related]
17. Primary pulmonary hypertension: molecular basis and potential for therapy.
Rudarakanchana N; Morrell NW
Expert Rev Mol Med; 2004 Mar; 6(6):1-15. PubMed ID: 15005857
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
Sztrymf B; Coulet F; Girerd B; Yaici A; Jais X; Sitbon O; Montani D; Souza R; Simonneau G; Soubrier F; Humbert M
Am J Respir Crit Care Med; 2008 Jun; 177(12):1377-83. PubMed ID: 18356561
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial hypertension: a look to the future.
Rubin LJ; Galiè N
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):89S-90S. PubMed ID: 15194184
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein receptor 2 mutations in adults and children with idiopathic pulmonary arterial hypertension: association with thyroid disease.
Roberts KE; Barst RJ; McElroy JJ; Widlitz A; Chada K; Knowles JA; Morse JH
Chest; 2005 Dec; 128(6 Suppl):618S. PubMed ID: 16373874
[No Abstract] [Full Text] [Related]
[Next] [New Search]
